ArticleJournal of cellular and molecular medicine2025
RETRACTION: Astragaloside IV Ameliorates Fat Metabolism in the Liver of Ageing Mice Through Targeting Mitochondrial Activity.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionZ. Luo, Y. Wang, M. Xue, F. Xia, L. Zhu, Y. Li, D. Jia, S. Chen, G. Xu and Y. Lei, "Astragaloside IV Ameliorates Fat Metabolism in the Liver of Ageing Mice Through Targeting Mitochondrial Activity," Journal of Cellular and Molecular Medicine 25, no. 18 (2021): 8863-8876, https://doi.org/10.1111/jcmm.16847. The above article, published online on 17 August 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party. The investigation revealed duplication between western blot bands presented in Figures 3A and 4B, where the duplicated bands represented different proteins. Furthermore, the IB: anti-β-actin bands in Figure 3A were found in an earlier publication by a different group of authors. The authors cooperated with the investigation and explained the duplication was a result of figure mismanagement. They also provided some supporting data; however, it did not correspond to the published figures. Given the nature of the concerns, the editors consider the results and conclusions of this article to be unreliable. The authors disagree with the retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.